Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer

被引:95
作者
Lopes, LB
Collett, JH
Bentley, MVLB
机构
[1] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, BR-14040903 Ribeirao Preto, SP, Brazil
[2] Univ Manchester, Dept Pharm, Manchester M13 9PL, Lancs, England
基金
巴西圣保罗研究基金会;
关键词
monoolein; cyclosporin A; topical delivery; penetration enhancer; in vitro permeation;
D O I
10.1016/j.ejpb.2004.12.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Topical delivery, of cyclosporin A (CysA) is of great interest for the treatment of autoimmune skin disorders, but it. is frequently ineffective due to poor drug penetration in the skin. The present study was aimed at investigating whether the presence of monoolein (a lipidic penetration enhancer) in a preparation of propylene glycol can improve CysA delivery to the skin. CysA was incorporated in a propylene glycol preparation containing 5-70% (w/w) of monoolein. The topical (to the skin) and transdermal (across the skin) delivery of CysA were evaluated in vitro using porcine ear skin mounted in a Franz diffusion cell. CysA was quantified by UV-HPLC. At 5%, monoolein increased only the transdermal delivery of CysA. At 10%, it increased both topical and transdermal delivery. When the concentration of monoolein was further increased (20-70% w/w), an interesting phenomenon was observed: the topical delivery of CysA was still elevated but its transdermal delivery was substantially reduced. It was concluded that monoolein (in propylene glycol formulations) can promote the, topical delivery of CysA with reduced transdermal delivery. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 34 条
[1]   Novel mechanisms and devices to enable successful transdermal drug delivery [J].
Barry, BW .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (02) :101-114
[2]   Breaching the skin's barrier to drugs [J].
Barry, BW .
NATURE BIOTECHNOLOGY, 2004, 22 (02) :165-167
[3]  
BHATIA KB, 1987, J PHARM SCI, V86, P462
[4]   Iontophoresis of lecithin vesicles of cyclosporin A [J].
Boinpally, RR ;
Zhou, SL ;
Devraj, G ;
Anne, PK ;
Poondru, S ;
Jasti, BR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 274 (1-2) :185-190
[5]   MECHANISM OF ACTION AND RATIONALE FOR CYCLOSPORINE-A IN PSORIASIS [J].
BOREL, JF .
BRITISH JOURNAL OF DERMATOLOGY, 1990, 122 :5-12
[6]   Drug delivery from a liquid crystalline base across Visking and human stratum corneum [J].
Carr, MG ;
Corish, J ;
Corrigan, OI .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 157 (01) :35-42
[7]   Validation of chromatographic methods in biomedical analysis - Viewpoint and discussion [J].
Causon, R .
JOURNAL OF CHROMATOGRAPHY B, 1997, 689 (01) :175-180
[8]   PERCUTANEOUS-ABSORPTION AND DERMAL DELIVERY OF CYCLOSPORINE-A [J].
CHOI, HK ;
FLYNN, GL ;
AMIDON, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (05) :581-583
[9]   Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants [J].
Christians, U ;
Jacobsen, W ;
Serkova, N ;
Benet, LZ ;
Vidal, C ;
Sewing, KF ;
Manns, MP ;
Kirchner, GI .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 748 (01) :41-53
[10]  
DOWTON SM, 1993, STP PHARMA SCI, V3, P404